IM Cannabis Corp. reports Q3 revenue of $13.9 million and net loss of $3.9 million

IM Cannabis Corp. reported revenue of $13.9 million for the third quarter of 2025, unchanged from the same period in 2024. Gross profit decreased by 13% to $2.7 million, with gross margin also declining to 20% from 23% in Q3 2024. The company recorded a net loss of $3.9 million, compared to a net loss of $1.1 million in Q3 2024, mainly due to a one-time goodwill and intangible asset impairment of $3.1 million. Excluding this impairment, net loss was $0.8 million. Non-IFRS adjusted EBITDA loss was $0.6 million, compared to a loss of $0.2 million in Q3 2024. General and administrative expenses were stable at $2.4 million, while selling and marketing expenses decreased by 7% to $1.4 million. Cash and restricted cash on hand as of September 30, 2025, was $2.3 million. The company noted ongoing regulatory changes in Germany could affect sales, and stated it is assessing new business activities as part of a strategic review. The financial statements include a note on the company’s ability to continue as a going concern. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IM Cannabis Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN22554) on November 13, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)